Patriot Financial Group Insurance Agency, LLC Fate Therapeutics Inc Transaction History

Patriot Financial Group Insurance Agency, LLC

$704 Million
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$17.78 - $42.39 $1,386 - $3,306	-78 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$29.67 - $60.28 $2,106 - $4,279	71 Added 1014.29%	78 $3,000
Q4 2021 Jan 10, 2022	SELL	$47.84 - $64.34 $1,674 - $2,251	-35 Reduced 83.33%	7 $0
Q3 2021 Nov 24, 2021	BUY	$59.27 - $95.73 $2,489 - $4,020	42 New	42 $2,000

Others Institutions Holding FATE

# of Institutions

177

Shares Held

113M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$17.1 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$13.2 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$7.24 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$6.83 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $126M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account